Literature DB >> 18984165

Neurofibromin regulation of ERK signaling modulates GABA release and learning.

Yijun Cui1, Rui M Costa, Geoffrey G Murphy, Ype Elgersma, Yuan Zhu, David H Gutmann, Luis F Parada, Istvan Mody, Alcino J Silva.   

Abstract

We uncovered a role for ERK signaling in GABA release, long-term potentiation (LTP), and learning, and show that disruption of this mechanism accounts for the learning deficits in a mouse model for learning disabilities in neurofibromatosis type I (NF1). Our results demonstrate that neurofibromin modulates ERK/synapsin I-dependent GABA release, which in turn modulates hippocampal LTP and learning. An Nf1 heterozygous null mutation, which results in enhanced ERK and synapsin I phosphorylation, increased GABA release in the hippocampus, and this was reversed by pharmacological downregulation of ERK signaling. Importantly, the learning deficits associated with the Nf1 mutation were rescued by a subthreshold dose of a GABA(A) antagonist. Accordingly, Cre deletions of Nf1 showed that only those deletions involving inhibitory neurons caused hippocampal inhibition, LTP, and learning abnormalities. Importantly, our results also revealed lasting increases in GABA release triggered by learning, indicating that the mechanisms uncovered here are of general importance for learning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984165      PMCID: PMC2673196          DOI: 10.1016/j.cell.2008.09.060

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  Computer-assisted behavioral assessment of Pavlovian fear conditioning in mice.

Authors:  S G Anagnostaras; S A Josselyn; P W Frankland; A J Silva
Journal:  Learn Mem       Date:  2000-01       Impact factor: 2.460

2.  A necessity for MAP kinase activation in mammalian spatial learning.

Authors:  J C Selcher; C M Atkins; J M Trzaskos; R Paylor; J D Sweatt
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

3.  Forebrain-specific knockout of B-raf kinase leads to deficits in hippocampal long-term potentiation, learning, and memory.

Authors:  Adele P Chen; Masuo Ohno; K Peter Giese; Ralf Kühn; Rachel L Chen; Alcino J Silva
Journal:  J Neurosci Res       Date:  2006-01       Impact factor: 4.164

4.  The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.

Authors:  Weidong Li; Yijun Cui; Steven A Kushner; Robert A M Brown; J David Jentsch; Paul W Frankland; Tyrone D Cannon; Alcino J Silva
Journal:  Curr Biol       Date:  2005-11-08       Impact factor: 10.834

5.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

Review 6.  Neurofibromatosis type 1.

Authors:  K North
Journal:  Am J Med Genet       Date:  2000

7.  Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy.

Authors:  N Hájos; Z Nusser; E A Rancz; T F Freund; I Mody
Journal:  Eur J Neurosci       Date:  2000-03       Impact factor: 3.386

8.  Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.

Authors:  Balazs Hegedus; Biplab Dasgupta; Jung Eun Shin; Ryan J Emnett; Elizabeth K Hart-Mahon; Lynda Elghazi; Ernesto Bernal-Mizrachi; David H Gutmann
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

9.  Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.

Authors:  N Rueda; J Flórez; C Martínez-Cué
Journal:  Neurosci Lett       Date:  2008-01-15       Impact factor: 3.046

10.  Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB.

Authors:  Clare Guilding; Kara McNair; Trevor W Stone; Brian J Morris
Journal:  Eur J Neurosci       Date:  2007-01       Impact factor: 3.386

View more
  211 in total

Review 1.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

Review 2.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

3.  ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.

Authors:  Yuying Wang; Joel M Brittain; Sarah M Wilson; Cynthia M Hingtgen; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2010-06       Impact factor: 1.757

Review 4.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

Review 5.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

6.  HCN2 channels in local inhibitory interneurons constrain LTP in the hippocampal direct perforant path.

Authors:  Lucas Matt; Stylianos Michalakis; Franz Hofmann; Verena Hammelmann; Andreas Ludwig; Martin Biel; Thomas Kleppisch
Journal:  Cell Mol Life Sci       Date:  2010-07-10       Impact factor: 9.261

7.  Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentation.

Authors:  Corina Anastasaki; Nicholas Rensing; Kevin J Johnson; Michael Wong; David H Gutmann
Journal:  J Sleep Res       Date:  2019-01-04       Impact factor: 3.981

8.  ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.

Authors:  Yuan Wang; Edward Kim; Xiaojing Wang; Bennett G Novitch; Kazuaki Yoshikawa; Long-Sheng Chang; Yuan Zhu
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

9.  Neurofibromin is the major ras inactivator in dendritic spines.

Authors:  Ana F Oliveira; Ryohei Yasuda
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Authors:  A Omrani; T van der Vaart; E Mientjes; G M van Woerden; M R Hojjati; K W Li; D H Gutmann; C N Levelt; A B Smit; A J Silva; S A Kushner; Y Elgersma
Journal:  Mol Psychiatry       Date:  2015-04-28       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.